Allianz Asset Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.55M | Buy |
64,000
+12,400
| +24% | +$1.19M | 0.01% | 1116 |
|
|
2025
Q4 | $4.96M | Buy |
51,600
+6,100
| +13% | +$593K | 0.01% | 1145 |
|
|
2025
Q3 | $4.33M | Sell |
45,500
-15,500
| -25% | -$1.42M | ﹤0.01% | 1176 |
|
|
2025
Q2 | $5.32M | Buy |
61,000
+5,300
| +10% | +$449K | 0.01% | 1086 |
|
|
2025
Q1 | $5.01M | Buy |
55,700
+24,000
| +76% | +$2.15M | 0.01% | 1107 |
|
|
2024
Q4 | $2.53M | Sell |
31,700
-3,400
| -10% | -$294K | ﹤0.01% | 1332 |
|
|
2024
Q3 | $3.16M | Buy |
35,100
+5,200
| +17% | +$437K | ﹤0.01% | 1238 |
|
|
2024
Q2 | $2.35M | Buy |
29,900
+28,100
| +1,561% | +$2.3M | ﹤0.01% | 1255 |
|
|
2024
Q1 | $157K | Sell |
1,800
-21,200
| -92% | -$1.81M | ﹤0.01% | 1880 |
|
|
2023
Q4 | $1.89M | Sell |
23,000
-58,400
| -72% | -$4.45M | ﹤0.01% | 1349 |
|
|
2023
Q3 | $6.38M | Buy |
81,400
+40,000
| +97% | +$3.35M | 0.01% | 897 |
|
|
2023
Q2 | $3.65M | Sell |
41,400
-5,200
| -11% | -$448K | 0.01% | 992 |
|
|
2023
Q1 | $3.76M | Sell |
46,600
-13,600
| -23% | -$1.11M | 0.01% | 1088 |
|
|
2022
Q4 | $4.68M | Buy |
60,200
+12,400
| +26% | +$1.01M | 0.01% | 940 |
|
|
2022
Q3 | $3.86M | Buy |
47,800
+28,900
| +153% | +$2.6M | 0.01% | 989 |
|
|
2022
Q2 | $1.7M | Sell |
18,900
-6,900
| -27% | -$699K | ﹤0.01% | 1479 |
|
|
2022
Q1 | $2.86M | Buy |
25,800
+13,700
| +113% | +$1.45M | ﹤0.01% | 1459 |
|
|
2021
Q4 | $1.25M | Sell |
12,100
-49,100
| -80% | -$5.69M | ﹤0.01% | 1801 |
|
|
2021
Q3 | $7.67M | Buy |
61,200
+30,600
| +100% | +$3.96M | 0.01% | 1117 |
|
|
2021
Q2 | $3.8M | Buy |
+30,600
| New | +$3.84M | ﹤0.01% | 1237 |
|
|
2020
Q1 | – | Sell |
-145,100
| Closed | -$16.5M | – | 2647 |
|
|
2019
Q4 | $16.5M | Buy |
145,100
+1,500
| +1% | +$165K | 0.02% | 878 |
|
|
2019
Q3 | $15.6M | Buy |
143,600
+8,700
| +6% | +$908K | 0.02% | 883 |
|
|
2019
Q2 | $13.1M | Buy |
134,900
+85,200
| +171% | +$7.78M | 0.01% | 1029 |
|
|
2019
Q1 | $4.53M | Sell |
49,700
-12,000
| -19% | -$1.07M | ﹤0.01% | 1508 |
|
|
2018
Q4 | $5.61M | Sell |
61,700
-22,700
| -27% | -$2.12M | 0.01% | 1354 |
|
|
2018
Q3 | $8.3M | Sell |
84,400
-12,900
| -13% | -$1.19M | 0.01% | 1354 |
|
|
2018
Q2 | $8.33M | Buy |
97,300
+10,100
| +12% | +$844K | 0.01% | 1326 |
|
|
2018
Q1 | $7M | Sell |
87,200
-150,900
| -63% | -$12.4M | 0.01% | 1406 |
|
|
2017
Q4 | $19.2M | Sell |
238,100
-79,000
| -25% | -$6.33M | 0.02% | 991 |
|
|
2017
Q3 | $24.7M | Buy |
317,100
+73,000
| +30% | +$6.06M | 0.02% | 879 |
|
|
2017
Q2 | $21.7M | Sell |
244,100
-62,800
| -20% | -$5.3M | 0.02% | 926 |
|
|
2017
Q1 | $24.7M | Buy |
306,900
+7,900
| +3% | +$617K | 0.02% | 888 |
|
|
2016
Q4 | $21.3M | Buy |
299,000
+74,900
| +33% | +$5.88M | 0.02% | 964 |
|
|
2016
Q3 | $19.4M | Buy |
224,100
+72,600
| +48% | +$6.33M | 0.02% | 994 |
|
|
2016
Q2 | $13.1M | Buy |
151,500
+96,800
| +177% | +$7.83M | 0.01% | 1112 |
|
|
2016
Q1 | $4.1M | Buy |
+54,700
| New | +$4.12M | ﹤0.01% | 1525 |
|
|
2015
Q1 | – | Sell |
-40,400
| Closed | -$2.92M | – | 2306 |
|
|
2014
Q4 | $2.92M | Buy |
40,400
+27,100
| +204% | +$1.88M | ﹤0.01% | 1406 |
|
|
2014
Q3 | $824K | Buy |
+13,300
| New | +$846K | ﹤0.01% | 1723 |
|
Other funds holding MDT
VCM
VPM
Allianz Asset Management's MDT Position: Q1 2026 in Review
Allianz Asset Management reduced its Medtronic (MDT) stake by 18% in Q1 2026, selling an estimated $31.4M and leaving 1,519,301 shares worth $132M. The position accounts for 0.14% of the portfolio, ranked #144.
Allianz Asset Management first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $437M in Q3 2013. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Allianz Asset Management held 1,519,301 shares of Medtronic worth $132M as of Q1 2026.
- Allianz Asset Management sold 327,582 Medtronic shares in Q1 2026, an estimated $31.4M.
- Medtronic made up 0.14% of Allianz Asset Management's portfolio in Q1 2026, its #144 holding.
- Allianz Asset Management first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
- Allianz Asset Management's Medtronic position peaked at $437M in Q3 2013.
- 2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.